Atropos Health and Seqster joined forces to address historical diversity and inclusion challenges in clinical trials. The partnership seeks to enable the swift creation of turnkey patient registries that generate real world evidence from existing registries in under 48 hours.
UBC partners with Seqster to leverage the latter's technology to allow patients to gather their own medical records for decentralized clinical trials. This could help speed up clinical trial enrollment.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Seqster, a San Diego based company looking to build a platform for patients’ health records, DNA data and wearable data, raised $12 million in a funding round led by OmniHealth Holdings.
The pharmaceutical company will use Seqster’s system to speed up onboarding for clinical trials and to improve patient engagement.
The company's technology collects and aggregates medical data from disparate sources including EHR systems, labs, pharmacies, wearables and health apps.
The company launched its platform earlier this year and claims to be able to integrate data from a range of sources including genomics data, electronic medical records and consumer wearables.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.